Takeda Pharmaceutical (TAK) revenue

Revenue · fiscal 2026
¥4.51T

Takeda Pharmaceutical (TAK) reported revenue of ¥4.51T in fiscal 2026 (the year ended March 31, 2026). That is 1.7% lower than the ¥4.58T of fiscal 2025. Figures as of 18 Nov 2026, 09:39 UTC, from Yahoo Finance.

Key facts

Revenue, fiscal 2026
¥4.51T
Change on fiscal 2025
−1.7%
Highest on record
¥4.58Tfiscal 2025
Lowest on record
¥4.03Tfiscal 2023
Fiscal years on record
42023–2026

Figures as of . Statements from Yahoo Finance. Amounts are in JPY. Figures, not advice.

Takeda Pharmaceutical revenue, in more detail

Across the 4 fiscal years on record (2023–2026), the highest was ¥4.58T in fiscal 2025 and the lowest ¥4.03T in fiscal 2023.

History · 4 fiscal years

Revenue by fiscal year

Takeda Pharmaceutical revenue, year by year

Takeda Pharmaceutical (TAK) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2026¥4.51T 1.7% down
2025¥4.58T 7.5% up
2024¥4.26T 5.9% up
2023¥4.03T—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Takeda Pharmaceutical and comparable companies
CompanyRevenueFiscal year
Takeda Pharmaceutical TAK¥4.51T2026
Cencora COR$321.33B2025
Boston Scientific BSX$20.07B2025
Cardinal Health CAH$254.25B2026
argenx ARGX$4.15B2025
Edwards Lifesciences EW$6.07B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on TAK

Takeda Pharmaceutical, figure by figure

Takeda Pharmaceutical (TAK) overview: price, valuation and scorecardAll health care companies by market value

Takeda Pharmaceutical revenue: questions and answers

What is Takeda Pharmaceutical's revenue?

Takeda Pharmaceutical (TAK) reported revenue of ¥4.51T in fiscal 2026 (the year ended March 31, 2026). That is 1.7% lower than the ¥4.58T of fiscal 2025.

What are the highest and lowest revenue figures on record for Takeda Pharmaceutical?

Across the 4 fiscal years on record (2023–2026), the highest was ¥4.58T in fiscal 2025 and the lowest ¥4.03T in fiscal 2023.

How is Takeda Pharmaceutical's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Takeda Pharmaceutical it is on record here for 4 fiscal years, 2023 to 2026.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Takeda Pharmaceutical (TAK) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/TAK/revenue

Underlying data: Yahoo Finance.